Abstract 6867: Triplet combination of monzosertib, a potent CDC7 inhibitor, with DNMT and BCL2 inhibitors is highly active in human AML xenograft mouse models
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Hatsuo Furuichi, Hiroko Endo, Akinori Arimura, Yu Nishioka, Masaaki Sawa
Institutions: Instacart (United States), Keymed Biosciences Inc. (China)
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W6903597214
Cites:
Cited by:
Related to: